These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

729 related articles for article (PubMed ID: 21703876)

  • 21. Prevalence of platelet nonresponsiveness to aspirin in patients treated for secondary stroke prophylaxis and in patients with recurrent ischemic events.
    Gengo FM; Rainka M; Robson M; Gengo MF; Forrest A; Hourihane M; Bates V
    J Clin Pharmacol; 2008 Mar; 48(3):335-43. PubMed ID: 18223144
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antiplatelet agents in stroke prevention: acute and long-term treatment strategies.
    Weber R; Weimar C; Diener HC
    Hamostaseologie; 2009 Nov; 29(4):326-33. PubMed ID: 19882077
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Risk factor profile and management of cerebrovascular patients in the REACH Registry.
    Röther J; Alberts MJ; Touzé E; Mas JL; Hill MD; Michel P; Bhatt DL; Aichner FT; Goto S; Matsumoto M; Ohman EM; Okada Y; Uchiyama S; D'Agostino R; Hirsch AT; Wilson PW; Steg PG;
    Cerebrovasc Dis; 2008; 25(4):366-74. PubMed ID: 18337635
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical profiles, complications, and disability in cocaine-related ischemic stroke.
    Bhattacharya P; Taraman S; Shankar L; Chaturvedi S; Madhavan R
    J Stroke Cerebrovasc Dis; 2011; 20(5):443-9. PubMed ID: 20813550
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pretreatment with aspirin and etiology of first-ever ischemic stroke in young and middle-aged patients.
    Telman G; Kouperberg E; Sprecher E; Yarnitsky D
    J Neurol Sci; 2009 Jun; 281(1-2):2-5. PubMed ID: 19351569
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The BC genotype of the VNTR polymorphism of platelet glycoprotein Ibalpha is overrepresented in patients with recurrent stroke regardless of aspirin therapy.
    Cervera A; Tàssies D; Obach V; Amaro S; Reverter JC; Chamorro A
    Cerebrovasc Dis; 2007; 24(2-3):242-6. PubMed ID: 17630485
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A comparison of aspirin and clopidogrel with or without proton pump inhibitors for the secondary prevention of cardiovascular events in patients at high risk for gastrointestinal bleeding.
    Hsiao FY; Tsai YW; Huang WF; Wen YW; Chen PF; Chang PY; Kuo KN
    Clin Ther; 2009 Sep; 31(9):2038-47. PubMed ID: 19843493
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Medical prevention of stroke, 2003.
    Kirshner HS
    South Med J; 2003 Apr; 96(4):354-8. PubMed ID: 12916553
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Current guidelines on antiplatelet agents for secondary prevention of noncardiogenic stroke: an evidence-based review.
    Simmons BB; Yeo A; Fung K; ;
    Postgrad Med; 2010 Mar; 122(2):49-53. PubMed ID: 20203455
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Plasma triglycerides as predictors of platelet responsiveness to aspirin in patients after first ischemic stroke.
    Karepov V; Tolpina G; Kuliczkowski W; Serebruany V
    Cerebrovasc Dis; 2008; 26(3):272-6. PubMed ID: 18648200
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antiplatelet and anticoagulant therapy in patients with giant cell arteritis.
    Lee MS; Smith SD; Galor A; Hoffman GS
    Arthritis Rheum; 2006 Oct; 54(10):3306-9. PubMed ID: 17009265
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antiplatelet therapy in ischemic stroke: variability in clinical trials and its impact on choosing the appropriate therapy.
    Biller J
    J Neurol Sci; 2009 Sep; 284(1-2):1-9. PubMed ID: 19380153
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of hypoglycemic drugs on aspirin resistance in patients with diabetes mellitus.
    Ariturk Z; Islamoglu Y; Gündüz E; Yavuz C; Cil H; Tekbas E; Soydinc S; Kaya H; Elbey MA
    Eur Rev Med Pharmacol Sci; 2012 May; 16(5):617-21. PubMed ID: 22774402
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antithrombotic drugs for the secondary prevention of ischemic stroke.
    Nenci GG; Goracci S
    Ann Ital Med Int; 2000; 15(4):282-90. PubMed ID: 11202630
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation on the compliance with secondary prevention and influence factors of ischemic stroke in Hainan province, China.
    Su Q; Yuan K; Long F; Wan Z; Li C; Cai Y; Zeng C; Wu Y; Wu H; Liu S; Li P; Zhou J; Chen C; Wang D; Yan L; Zhang Y; Dai M
    Vascular; 2014 Jun; 22(3):181-7. PubMed ID: 23929417
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Switching from aspirin to clopidogrel in patients with aspirin resistance after an ischemic stroke. Is it a good solution?
    Castilla-Guerra L; Fernandez-Moreno Mdel C; Navas-Alcantara MS; Jimenez-Gonzalo F
    Eur J Intern Med; 2014 Mar; 25(3):e40-1. PubMed ID: 24484620
    [No Abstract]   [Full Text] [Related]  

  • 37. Secondary stroke prevention with antiplatelet drugs: have we reached the ceiling?
    Diener HC
    Int J Stroke; 2006 Feb; 1(1):4-8. PubMed ID: 18706062
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ischemic stroke: prevalence of modifiable risk factors in male and female patients in Pakistan.
    Khan NI; Naz L; Mushtaq S; Rukh L; Ali S; Hussain Z
    Pak J Pharm Sci; 2009 Jan; 22(1):62-7. PubMed ID: 19168423
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of discontinuing aspirin therapy on the risk of brain ischemic stroke.
    Maulaz AB; Bezerra DC; Michel P; Bogousslavsky J
    Arch Neurol; 2005 Aug; 62(8):1217-20. PubMed ID: 16087761
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Aspirin dosing for the prevention and treatment of ischemic stroke: an indication-specific review of the literature.
    Ansara AJ; Nisly SA; Arif SA; Koehler JM; Nordmeyer ST
    Ann Pharmacother; 2010 May; 44(5):851-62. PubMed ID: 20388864
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 37.